Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine / Deanna L. Kelly en The Journal of Clinical Psychiatry, Año 2010 - Vol. 71 - No. 3 (Marzo)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 3 (Marzo) . - pp. 304-11 Título : Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine : a retrospective cohort study Tipo de documento: texto impreso Autores: Deanna L. Kelly, Autor ; Robert P. McMahon, Autor ; Fang Liu, Autor Fecha de publicación: 2022 Artículo en la página: pp. 304-11 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Enfermedades Cardiovasculares, Enfermedad crónica, Clozapina, Maryland, Esquizofrenia. Resumen: Cardiovascular disease (CVD) mortality in schizophrenia is more frequent than in the general population. Whether second-generation antipsychotics (SGAs) increase risk of CVD morbidity and mortality has yet to be determined. Link: ./index.php?lvl=notice_display&id=28162 [artículo] Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine : a retrospective cohort study [texto impreso] / Deanna L. Kelly, Autor ; Robert P. McMahon, Autor ; Fang Liu, Autor . - 2022 . - pp. 304-11. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 3 (Marzo) . - pp. 304-11 Palabras clave: Antipsicóticos, Enfermedades Cardiovasculares, Enfermedad crónica, Clozapina, Maryland, Esquizofrenia. Resumen: Cardiovascular disease (CVD) mortality in schizophrenia is more frequent than in the general population. Whether second-generation antipsychotics (SGAs) increase risk of CVD morbidity and mortality has yet to be determined. Link: ./index.php?lvl=notice_display&id=28162

Participants with schizophrenia retain the information necessary for informed consent during clinical trials / Bernard A. Fischer en The Journal of Clinical Psychiatry, Año 2013 - Vol.74 - No.6 (Junio)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2013 - Vol.74 - No.6 (Junio) . - pp. 622-627 Título : Participants with schizophrenia retain the information necessary for informed consent during clinical trials Tipo de documento: texto impreso Autores: Bernard A. Fischer, Autor ; Robert P. McMahon, Autor ; Walter A. Meyer, Autor Fecha de publicación: 2022 Artículo en la página: pp. 622-627 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Consentimiento informado, Competencia mental, Psicología esquizofrénica, Conceptos erróneos terapéuticos Resumen: Cognitive impairment is a characteristic of schizophrenia. This impairment may affect the retention of information required for ongoing knowledgeable participation in clinical trials. This study monitored retention of study-related knowledge-including assessment of therapeutic misconception-in people with stable, DSM-IV schizophrenia during participation in placebo-controlled clinical trials of adjunctive agents. Link: ./index.php?lvl=notice_display&id=27862 [artículo] Participants with schizophrenia retain the information necessary for informed consent during clinical trials [texto impreso] / Bernard A. Fischer, Autor ; Robert P. McMahon, Autor ; Walter A. Meyer, Autor . - 2022 . - pp. 622-627. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2013 - Vol.74 - No.6 (Junio) . - pp. 622-627 Palabras clave: Consentimiento informado, Competencia mental, Psicología esquizofrénica, Conceptos erróneos terapéuticos Resumen: Cognitive impairment is a characteristic of schizophrenia. This impairment may affect the retention of information required for ongoing knowledgeable participation in clinical trials. This study monitored retention of study-related knowledge-including assessment of therapeutic misconception-in people with stable, DSM-IV schizophrenia during participation in placebo-controlled clinical trials of adjunctive agents. Link: ./index.php?lvl=notice_display&id=27862

---

1 (1 - 2 / 2)